KR830006265A - 복소환 화합물의 제조방법 - Google Patents

복소환 화합물의 제조방법 Download PDF

Info

Publication number
KR830006265A
KR830006265A KR1019810002871A KR810002871A KR830006265A KR 830006265 A KR830006265 A KR 830006265A KR 1019810002871 A KR1019810002871 A KR 1019810002871A KR 810002871 A KR810002871 A KR 810002871A KR 830006265 A KR830006265 A KR 830006265A
Authority
KR
South Korea
Prior art keywords
formula
compound
group
hydrogen
reacted
Prior art date
Application number
KR1019810002871A
Other languages
English (en)
Other versions
KR850000388B1 (ko
Inventor
자이프 울리히
볼렌베르크 베르너
뮐러 베른트
미첼 구드룬
Original Assignee
프란츠 비르츠, 지그프리트 헤를링
그뤼넨탈 게젤샤프트 미트 베슈렝크터 하프퉁
지그프리트 헤를링
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프란츠 비르츠, 지그프리트 헤를링, 그뤼넨탈 게젤샤프트 미트 베슈렝크터 하프퉁, 지그프리트 헤를링 filed Critical 프란츠 비르츠, 지그프리트 헤를링
Publication of KR830006265A publication Critical patent/KR830006265A/ko
Application granted granted Critical
Publication of KR850000388B1 publication Critical patent/KR850000388B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Control Of Positive-Displacement Air Blowers (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Sheet Holders (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

내용 없음

Description

복소환 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 구조식(Ⅱ)의 화합물을 산소부재하, 10 내지 30℃에서 강염기를 함유하는 용매존재하에 1 내지 6몰의 구조식(Ⅲ)의 화합물과 반응시키고 R6가 수소인 경우에는 카복실그룹 COOR6를 에스테르화한 후 보호 그룹 R5및 R5(존재할 경우)를 제거하여 구조식(Ⅳ)의 화합물을 수득하고 이 화합물을 0 내지 30℃에서 불활성 용매 존재하에 브롬화제 또는 요드화제와 반응시켜(물 및 산결합제 존재하에서도 반응시킬 수 있으며) 할로겐화 및 폐환시켜 구조식(V)의 화합물을 얻고 0 내지 90℃에서 1 내지 5몰의 염기로 처리하여 탈할로겐화수소화시켜 구조식(Ia)의 화합물을 얻고 에스테르그룹 COOR7을 검화하여 다음 구조식(I)의 복소환 화합물을 제조하는 방법.
    상기 구조식에서
    R1은 수소, 약학적으로 무독한 양이온 또는 약학적으로 무독한 에스테르화 형으로 존재하는 알콜잔기이고
    R2는 수소 또는 메틸그룹
    A는 -CH2-CH2-,(트랜스)-CH=CH- 또는 -C≡C-이며
    B는 다음 구조식의 탄소수 5 내지 9의 알킬기
    (여기서 R3와 R4는 서로 같거나 다른 것으로서 각각 수소, 메틸 또는 에틸을 나타내며) 또는 사이클로 헥실기 또는 4' 위치에 메틸 또는 에틸기로 치환된 사이클로헥실기이고
    D는 -CH2-CH2-,(트랜스)=CH=CH- 또는 -CH=C Hal- (여기서 Hal은 염소, 브롬 또는 요드)이고
    R5및 R5는 서로 같거나 다른 것으로서 각각 수소 또는 완화한 조건하에서 분리시킬 수 있는 보호그룹 특히 테트라하이드로피라닐 또는 트리메틸실릴그룹,
    R6는 수소 또는 탄소수 1 내지 6의 알킬기이고
    R7은 탄소수 1 내지 6의 알킬기이며
    X는 브롬 또는 요드이다.
  2. 다음 구조식의 화합물을 구조식(Ⅲ)의 화합물과 반응시키고 다른 과정은 특허청구 범위 1과 같이하여 신규 복소환 화합물인 [(5EZ,13E,9α,11α,15s)-2,3,4-트리노트-1,5-에테르-m-페닐렌-6,9-에폭시-11,15-디하이드록시-15-사이클로헥실-16,17,18,19,20-펜타노르]-프로스티-5,13-디에노산 및 이들의 염을 제조하는 방법.
    여기서 R5및 R5'는 구조식(Ⅱ)에서와 같다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810002871A 1980-08-08 1981-08-07 복소환 화합물 및 이의 이성체의 제조방법 KR850000388B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3029984A DE3029984C2 (de) 1980-08-08 1980-08-08 2-Oxabicyclo [3.3.0] octanderivate und diese enthaltende Arzneimittel
DEP3029984.4 1980-08-08

Publications (2)

Publication Number Publication Date
KR830006265A true KR830006265A (ko) 1983-09-20
KR850000388B1 KR850000388B1 (ko) 1985-03-25

Family

ID=6109130

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810002871A KR850000388B1 (ko) 1980-08-08 1981-08-07 복소환 화합물 및 이의 이성체의 제조방법

Country Status (23)

Country Link
US (1) US4372971A (ko)
EP (1) EP0045842B1 (ko)
JP (1) JPS5754180A (ko)
KR (1) KR850000388B1 (ko)
AT (1) ATE5884T1 (ko)
AU (1) AU542775B2 (ko)
CA (1) CA1169871A (ko)
DD (1) DD201590A5 (ko)
DE (2) DE3029984C2 (ko)
DK (1) DK154214C (ko)
ES (1) ES8301957A1 (ko)
FI (1) FI72973C (ko)
GR (1) GR75238B (ko)
HK (1) HK26187A (ko)
HU (1) HU184870B (ko)
IE (1) IE51308B1 (ko)
IL (1) IL63322A (ko)
MY (1) MY8600649A (ko)
NO (1) NO154166C (ko)
PT (1) PT73406B (ko)
SU (1) SU1072801A3 (ko)
YU (1) YU42416B (ko)
ZA (1) ZA814720B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65387A0 (en) * 1981-04-14 1982-05-31 Chinoin Gyogyszer Es Vegyeszet 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives and a process for the preparation thereof
HU188559B (en) * 1981-12-01 1986-04-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing new inter-m-phenylene-prostacyclin derivatives
IL67332A (en) * 1981-12-01 1985-12-31 Chinoin Gyogyszer Es Vegyeszet Inter-m-phenylene-prostacyclin analogues,process for the preparation thereof and pharmaceutical compositions containing them
HU190007B (en) * 1982-05-06 1986-08-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new aromatic prostacylin analogues
DE3317159A1 (de) * 1982-05-27 1983-12-01 Grünenthal GmbH, 5190 Stolberg Verfahren zur herstellung von 5z-formen von 2,3,4-trinor-1,5-inter-m-phenylen- prostacyclinderivaten
DE3914735A1 (de) * 1989-05-05 1990-11-08 Gruenenthal Gmbh Pharmakologisch wirksame ester, diese enthaltende arzneimittel und die herstellung dieser ester und arzneimittel

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933899A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE2 -oxa-phenylene compounds
US3933900A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGEo oxa-phenylene compounds
US3933896A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGF1.sub.β -oxa phenylene compounds
US3933898A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE1 -oxa phenylene compounds
US3933897A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGA1 -oxa-phenylene compounds
US3933895A (en) * 1972-10-30 1976-01-20 The Upjohn Company Oxa-phenylene compounds
DE2346706A1 (de) * 1973-09-17 1975-04-03 Hoechst Ag Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
US4238623A (en) * 1976-03-29 1980-12-09 Miles Laboratories, Inc. 5,6-Benzo analogues of prostaglandin
AU524786B2 (en) * 1977-03-07 1982-10-07 The Upjohn Company Prostacyclins
US4207257A (en) * 1977-04-18 1980-06-10 The Upjohn Company Inter-phenylene-13,14-dihydro-PG amides
US4100192A (en) * 1977-04-18 1978-07-11 The Upjohn Company Inter-phenylene-PG amides
IT1088036B (it) * 1977-11-25 1985-06-04 Erba Carlo Spa 15-epi-prostaciclina e prostaciclina analoghi
IT1099575B (it) 1978-07-20 1985-09-18 Erba Carlo Spa 20-metil-13,14-deidro-pgi2' suoi sali e suoi 16s- e 16r-metil derivati
US4180657A (en) * 1978-08-14 1979-12-25 The Upjohn Company Acyl-substituted phenyl esters of prostacyclin-type compounds
US4312810A (en) * 1978-11-22 1982-01-26 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds
DE2902809A1 (de) * 1979-01-25 1980-08-07 Hoechst Ag Neue analoga von prostacyclin

Also Published As

Publication number Publication date
DK154214C (da) 1989-03-13
JPS5754180A (en) 1982-03-31
DE3161958D1 (en) 1984-02-23
ES504618A0 (es) 1983-01-01
ZA814720B (en) 1982-07-28
PT73406B (fr) 1982-08-09
ATE5884T1 (de) 1984-02-15
FI72973C (fi) 1987-08-10
JPS6116393B2 (ko) 1986-04-30
DK350181A (da) 1982-02-09
NO154166C (no) 1986-07-30
DE3029984C2 (de) 1983-12-15
DD201590A5 (de) 1983-07-27
AU542775B2 (en) 1985-03-14
EP0045842B1 (de) 1984-01-18
EP0045842A1 (de) 1982-02-17
FI812452L (fi) 1982-02-09
MY8600649A (en) 1986-12-31
US4372971A (en) 1983-02-08
PT73406A (fr) 1981-08-01
GR75238B (ko) 1984-07-13
NO154166B (no) 1986-04-21
ES8301957A1 (es) 1983-01-01
SU1072801A3 (ru) 1984-02-07
IL63322A0 (en) 1981-10-30
HU184870B (en) 1984-10-29
IE811357L (en) 1982-02-08
YU42416B (en) 1988-08-31
CA1169871A (en) 1984-06-26
KR850000388B1 (ko) 1985-03-25
IL63322A (en) 1985-01-31
FI72973B (fi) 1987-04-30
HK26187A (en) 1987-04-10
NO812338L (no) 1982-02-09
YU179081A (en) 1983-06-30
DK154214B (da) 1988-10-24
DE3029984A1 (de) 1982-02-18
AU7246381A (en) 1982-02-11
IE51308B1 (en) 1986-11-26

Similar Documents

Publication Publication Date Title
KR840001156A (ko) 벤지미다졸 유도체의 제조방법
CA1079725A (en) Prostaglandin-acetylene analogues and process for their manufacture
KR830002693A (ko) 약제의 에테르류 및 중간체의 제조방법
KR830010112A (ko) 9-(1,3-디하이드록시-2-프로폭시메틸)-구아닌의 제조방법
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR830002772A (ko) 메탄디올의 페니실린 및 페니실란산 1,1-디옥사이드 와의 비스-에스테르
KR860008967A (ko) 입체 장해된 하이드록시페닐카복실 산 에스테르의 제조방법
KR840000463A (ko) 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법
KR860004088A (ko) 피플루 오로 알킬 비닐 중합체의 제조방법
KR830006265A (ko) 복소환 화합물의 제조방법
KR840000565A (ko) 세펨 화합물의 제조방법
KR880011122A (ko) 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물
KR830001941A (ko) β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법
ATE15029T1 (de) Neue prostacyclin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
KR840002406A (ko) 3위치가 티오메틸 복소환 그룹에 의해 치환된 신규의 세팔로스포린유도체의 제조방법세
IE32350B1 (en) Furanosides,process for their preparation and compositions containing them
KR840002855A (ko) Omt에스테르 유도체의 제조방법
ES436362A1 (es) Procedimiento para preparar acidos 3beta-hidroxi-2-(1-alque-nilsustituido)-5-oxociclopentano-1-heptanoicos.
CH608785A5 (en) Process for producing new N-acylglutamines
KR880012544A (ko) 벤젠설폰아미드 유도체 및 그의 제조방법
US3959363A (en) 15-Ethynyl-PFG2.sub.β
ES428047A1 (es) Un procedimiento para la preparacion de nuevos derivados de prostaglandina.
KR860008155A (ko) 벤조산 유도체의 제조방법
KR870003114A (ko) 테트라하이드로이소퀴놀린 유도체